Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | SIGLEC15 |
Upstream (Parents) |
---|
(<<) C9 → SIGLEC15 |
(<<) MMP13 → SIGLEC15 |
(<<) MMP9 → SIGLEC15 |
(<<) GPR126 → SIGLEC15 |
(<<) TNFRSF11A → SIGLEC15 |
Downstream (Children) |
---|
SIGLEC15 → KIAA0087 (>>) |
SIGLEC15 → OPCML (>>) |
SIGLEC15 → ST18 (>>) |
SIGLEC15 → SPRR2C (>>) |
SIGLEC15 → LOC647081///SDHD (>>) |
SIGLEC15 → MUC5B///MUC5AC (>>) |
SIGLEC15 → ALDH3B2 (>>) |
SIGLEC15 → DLG2 (>>) |
SIGLEC15 → SLC18A1 (>>) |
SIGLEC15 → SLC22A11 (>>) |
SIGLEC15 → IFNA6 (>>) |
SIGLEC15 → GLT25D2 (>>) |